These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 32990543)
1. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents. Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543 [TBL] [Abstract][Full Text] [Related]
2. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities. Yang M; Liu H; Zhang Y; Wang X; Xu Z Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents. Singh A; Kaur H; Arora S; Bedi PMS Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100368. PubMed ID: 34783073 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, antimicrobial evaluation, and in silico studies of quinoline-1H-1,2,3-triazole molecular hybrids. Awolade P; Cele N; Kerru N; Singh P Mol Divers; 2021 Nov; 25(4):2201-2218. PubMed ID: 32507981 [TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation. Kumar K; Sagar S; Esau L; Kaur M; Kumar V Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212 [TBL] [Abstract][Full Text] [Related]
6. Triazole tethered isatin-coumarin based molecular hybrids as novel antitubulin agents: Design, synthesis, biological investigation and docking studies. Singh H; Singh JV; Gupta MK; Saxena AK; Sharma S; Nepali K; Bedi PMS Bioorg Med Chem Lett; 2017 Sep; 27(17):3974-3979. PubMed ID: 28797799 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of novel substituted isatin-propylene-1H-1,2,3-triazole-4-methylene-moxifloxacin hybrids for their anti-mycobacterial activities. Yan X; Lv Z; Wen J; Zhao S; Xu Z Eur J Med Chem; 2018 Jan; 143():899-904. PubMed ID: 29227930 [TBL] [Abstract][Full Text] [Related]
8. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds. Guo H; Diao QP Curr Top Med Chem; 2020; 20(16):1499-1503. PubMed ID: 32156238 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus. Gatadi S; Gour J; Shukla M; Kaul G; Das S; Dasgupta A; Malasala S; Borra RS; Madhavi YV; Chopra S; Nanduri S Eur J Med Chem; 2018 Sep; 157():1056-1067. PubMed ID: 30176536 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and molecular docking studies of thymol based 1,2,3-triazole hybrids as thymidylate synthase inhibitors and apoptosis inducers against breast cancer cells. Alam MM; Malebari AM; Syed N; Neamatallah T; Almalki ASA; Elhenawy AA; Obaid RJ; Alsharif MA Bioorg Med Chem; 2021 May; 38():116136. PubMed ID: 33894490 [TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin Derivatives with Potential Antibacterial Activity against Methicillin- Resistant Staphylococcus Aureus (MRSA). Chen R; Xue H; Xu Y; Ma T; Liu Y; Zhang J; Shi X; Guo D Curr Top Med Chem; 2021; 21(27):2474-2482. PubMed ID: 34645377 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, Cytotoxicity and Antimicrobial Evaluation of New Coumarin-Tagged β-Lactam Triazole Hybrid. Dhawan S; Awolade P; Kisten P; Cele N; Pillay AS; Saha S; Kaur M; Jonnalagadda SB; Singh P Chem Biodivers; 2020 Jan; 17(1):e1900462. PubMed ID: 31788939 [TBL] [Abstract][Full Text] [Related]
13. The In Vitro Anticancer Activity and Potential Mechanism of Action of 1-[(1R,2S)-2-fluorocyclopropyl]Ciprofloxacin-(4-methyl/phenyl/benzyl-3- aryl)-1,2,4-triazole-5(4H)-thione Hybrids. Zhang YZ; Liu HL; He QS; Xu Z Curr Top Med Chem; 2020; 20(16):1493-1498. PubMed ID: 32156237 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents. Kadhim ZY; Alqaraghuli HGJ; Abd MT Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379 [TBL] [Abstract][Full Text] [Related]
16. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells. Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344 [TBL] [Abstract][Full Text] [Related]
17. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses. Rezki N; Almehmadi MA; Ihmaid S; Shehata AM; Omar AM; Ahmed HEA; Aouad MR Bioorg Chem; 2020 Oct; 103():104133. PubMed ID: 32745759 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER. Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119 [TBL] [Abstract][Full Text] [Related]
19. Novel ester tethered dihydroartemisinin-3-(oxime/thiosemicarbazide)isatin hybrids as potential anti-breast cancer agents: Synthesis, in vitro cytotoxicity and structure-activity relationship. Liu S; Wang S; Xu D; Pan B; Chen L; Zhao S; Xu Z; Zhou W Drug Dev Res; 2023 Sep; 84(6):1175-1182. PubMed ID: 37165798 [TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Anticancer and Antibacterial Activities of Quinoline-5-Sulfonamides. Zieba A; Pindjakova D; Latocha M; Plonka-Czerw J; Kusmierz D; Cizek A; Jampilek J Molecules; 2024 Aug; 29(17):. PubMed ID: 39274892 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]